Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nacera Sakek"'
Autor:
Cathy Giron, Gabriel Yazbek, D. Azria, Daniel Cassin, Nacera Sakek, Rafik Diab, Alain Rivière, Eric-Charles Antoine, Dominique Mille, Maya Hacini, H. Orfeuvre, William Jacot, Laurence Moureau-Zabotto, Laurent Bastit
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (12), pp.979-992. ⟨10.1016/j.bulcan.2015.09.004⟩
Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (12), pp.979-992. ⟨10.1016/j.bulcan.2015.09.004⟩
Resume But Decrire les pratiques courantes de prescription du G-CSF en France en cancerologie mammaire, par rapport aux recommandations de l’EORTC en vigueur. Methodes Etude prospective observationnelle conduite entre fevrier 2008 et septembre 2009
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811678c76f3221a8e24defa91956cd24
https://hal.umontpellier.fr/hal-02336942
https://hal.umontpellier.fr/hal-02336942
Autor:
William, Jacot, Eric-Charles, Antoine, Maya, Hacini, Cathy, Giron, Alain, Rivière, Laurence, Moureau-Zabotto, Daniel, Cassin, Gabriel, Yazbek, Hubert, Orfeuvre, Nacera, Sakek, Rafik, Diab, Laurent, Bastit, Dominique, Mille, David, Azria
Publikováno v:
Bulletin du cancer. 102(12)
To describe the French routine use of G-CSF in patients treated for breast cancer as per the EORTC recommendations.A prospective multicenter observational study conducted between February 2008 and September 2009 in 869 breast cancer patients treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4eacc544ff2dfe3c322b805c7ee7503
https://pubmed.ncbi.nlm.nih.gov/26597475
https://pubmed.ncbi.nlm.nih.gov/26597475
Publikováno v:
Journal of Clinical Oncology. 35:e17553-e17553
e17553 Background: Cisplatin toxicities substantially increased in elderly patients with head and neck cancer, when it is given as CRT. Bio-radiotherapy using cetuximab could offer a less toxic alternative. The purpose of this retrospective study is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd642fc94aa9571114b4e990c0bb2de9
https://doi.org/10.1200/jco.2017.35.15_suppl.e17553
https://doi.org/10.1200/jco.2017.35.15_suppl.e17553
Autor:
Pierre Nouyrigat, Louis-Marie Dourthe, Hélène Albrand, Frédéric Maloisel, Nadia Ali Amar, Jean-Luc Labourey, Nacera Sakek, Miguel Carreiro, Elisabeth Luporsi, Vincent Boulanger, Bérengère Narciso, Mauricette Michallet, Daniel Lepille, Jean-Loup Mouysset, Sophie Nahon, Pierre Soubeyran, Raouf Radji
Publikováno v:
BMC Cancer
Background The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies. The ORHEO (place of biOsimilaRs in the therapeutic management of anae
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc814141ee6052ec4b1d3ac5ef4b1e9
https://pubmed.ncbi.nlm.nih.gov/25011615
https://pubmed.ncbi.nlm.nih.gov/25011615